Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 50008056
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515285(CHEMBL4560840)
Affinity DataIC50: 8.20E+3nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515291(CHEMBL4580838)
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515296(CHEMBL4471676)
Affinity DataIC50: 1.63E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515297(CHEMBL4438604)
Affinity DataIC50: 1.73E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515288(CHEMBL4476592)
Affinity DataIC50: 1.77E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515287(CHEMBL4576117)
Affinity DataIC50: 2.20E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515280(CHEMBL4473255)
Affinity DataIC50: 2.35E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515293(CHEMBL4563826)
Affinity DataIC50: 2.36E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515283(CHEMBL4439607)
Affinity DataIC50: 2.60E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515286(CHEMBL4473248)
Affinity DataIC50: 3.06E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515284(CHEMBL4568083)
Affinity DataIC50: 3.25E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515278(CHEMBL4547833)
Affinity DataIC50: 3.90E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515290(CHEMBL4550776)
Affinity DataIC50: 4.00E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515282(CHEMBL4470846)
Affinity DataIC50: 4.25E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515281(CHEMBL4548717)
Affinity DataIC50: 4.25E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515289(CHEMBL4467863)
Affinity DataIC50: 4.50E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515292(CHEMBL4588791)
Affinity DataIC50: 4.85E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515294(CHEMBL4462769)
Affinity DataIC50: 4.95E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515279(CHEMBL4467162)
Affinity DataIC50: 5.00E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetToll-like receptor 7(Human)
University of Montpellier

Curated by ChEMBL
LigandPNGBDBM50515295(CHEMBL4462477)
Affinity DataIC50: 8.40E+4nMAssay Description:Antagonist activity at human TLR7 expressed in HEK-blue cells assessed as inhibition of CL264-induced NFkappaB activation after 24 hrs using qunati-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed